2AW-18458-00316
3 vaccinations
1 coded response
4 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 502 / IA
- Registered
- 2021-07-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-22
Dose 1 — Pfizer-BioNTech
-
2021-05-14
Dose 2 — Pfizer-BioNTech
-
2021-07-20
Registered in v-safe
- 2021-08-13
- 2021-11-12
-
2021-11-29
Dose 3 — Moderna
- 2022-05-30
-
2022-11-29
Survey response — 12 months, dose 3MedDRA: Office visit, Pregnancy — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: I'm pregnant again · Healthcare visit (other): OBGYN visitsMedDRA releases: 2024-11 · check-in free text available
-
2022-11-29
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professional1 call case(s)
- 2022-11-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-22 | Pfizer-BioNTech | No |
| 2 | 2021-05-14 | Pfizer-BioNTech | No |
| 3 | 2021-11-29 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-11-29 | Unsuccessful |
Free text
Release 12 — 12 months, dose 3
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release